title: [Male sexual dysfunction and obesity].
abstract: Obesity concerns more than 200 million people in the world, with an increasing prevalence in western countries. It is closely related to multiple medical conditions, such as diabetes and hypertension. It was recently shown that testosterone deficiency syndrome and erectile dysfunction (ED) are also linked to male obesity. In this group of patients, ED may be due to defects in corpus cavernosum relaxation, endocrine modifications and nerve signal alterations. Weight loss and increased physical activities can improve erectile function in 30% of obese patients. Additional medical treatments of ED enhance erectile function in more than 80% of patients. Self image improvement associated with appropriate erectile dysfunction medical treatment allow better sexual life and potentially increased motivation for weight loss.
authors: Service d'urologie, CHUV, Lausanne. ilaria.lucca@chuv.ch
authors: Ilaria
authors: I
authors: Lucca
authors: Darius A
authors: DA
authors: Paduch
authors: François
authors: F
authors: Pralong
authors: Laurent
authors: L
authors: Vaucher
mesh_terms: D000527:Alprostadil / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D009043:Motor Activity; D009765:Obesity / Q000150:complications*; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use; D015431:Weight Loss
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D014665:Vasodilator Agents; D000527:Alprostadil